Title of article :
SARS, MERS, and COVID-19 status in HIV-Positive Patients: A Systematic Review
Author/Authors :
Dolatian, Mahrohk Department of Reproductive Health midwifery - School of Nursing and Midwifery - Shahid Beheshti University of Medical Sciences , Ghiasi, Nasrin Department of Midwifery - Faculty of Medicine - Ilam University of Medical Sciences , Valizadeh, Rohollah Department of Epidemiology - School of Public Health - Iran University of Medical Sciences , Kellner, Steven J Mesencell Biotech International - Garth Business Centre, United Kingdom , Mahmoodi, Zohreh Social Determinants of Health Research Center - Alborz University of Medical Sciences , Nanbakhsh, Mohammad Department of Pulmonology - Shahid Motahari Hospital - Urmia University of Medical Sciences
Abstract :
Coronavirus can cause lots of viral diseases such as the common cold, novel coronavirus disease, severe acute respiratory syndrome coronavirus, and middle east respiratory syndrome coronavirus. Coronavirus and Human immunodeficiency virus (HIV) is considered RNA viruses. The use of antivirals in HIV-positive patients challenges the treatment process of the patients with SARA, MERS, and COVID-19. We reviewed the relevant studies in this regard to identify the status of COVID-19, MERS, and SARS in HIV-positive patients. According to this review, patients with HIV are not at risk for developing MERS, SARS, and COVID-19, but CD4<200 cells may increase the risk slightly. It should be noted that there is no difference regarding clinical signs, mortality, and length of the COIVD-19, SARS, and MERS in patients with HIV.
Keywords :
MERS , COVID-19 , SARS , HIV
Journal title :
Journal of Cellular and Molecular Anesthesia
